Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.
Aged
Aged, 80 and over
Biomarkers
/ blood
Centers for Medicare and Medicaid Services, U.S.
Cholesterol, LDL
/ blood
Diabetes Mellitus, Type 2
/ blood
Dyslipidemias
/ blood
Female
Health Status Disparities
Healthcare Disparities
/ ethnology
Heart Disease Risk Factors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/ therapeutic use
Male
Prognosis
Race Factors
Residence Characteristics
Retrospective Studies
Risk Assessment
Rural Health
Sex Factors
Social Determinants of Health
Time Factors
United States
/ epidemiology
Urban Health
Veterans Health
Veterans Health Services
Diabetes
Gender
Low-density lipoprotein
Race/ethnicity
Rural residence
Veterans
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
15 10 2020
15 10 2020
Historique:
received:
20
01
2020
accepted:
06
10
2020
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
2
2
2021
Statut:
epublish
Résumé
Cardiovascular (CV) disease is the leading cause of death among United States women. Rural residence and ethnic-minority status are individually associated with increased CV mortality. Managing dyslipidemia is important in the prevention of CV mortality. However, the impact of race/ethnicity and location of residence on sex differences in dyslipidemia management is not well understood. Therefore, we sought to understand the joint effects of race/ethnicity and location of residence on lipid management differences between veteran men and women with type 2 diabetes (T2D). Veterans Health Administration and Centers for Medicare and Medicaid Services data were used to perform a longitudinal cohort study of veterans with T2D (2007-2016). Mixed effects logistic regression with a random intercept was used to model the association between sex and low-density lipoprotein (LDL) > 100 mg/dL and its interaction with race/ethnicity and location of residence after adjusting for all measured covariates. When female sex and rural location of residence were both present, they were associated with an antagonistic harmful effect on LDL. Similar antagonistic harmful effects on LDL were observed when the joint effect of female sex and several minority race/ethnicity groups were evaluated. After adjusting for measured covariates, the odds of LDL > 100 mg/dL were higher for urban women (OR = 2.66, 95%CI 2.48-2.85) and rural women (OR = 3.26, 95%CI 2.94-3.62), compared to urban men. The odds of LDL > 100 mg/dL was the highest among non-Hispanic Black (NHB) women (OR = 5.38, 95%CI 4.45-6.51) followed by non-Hispanic White (NHW) women (OR = 2.59, 95%CI 2.44-2.77), and Hispanic women (OR = 2.56, 95%CI 1.79-3.66). Antagonistic harmful effects on LDL were observed when both female sex and rural location of residence were present. These antagonistic effects on LDL were also present when evaluating the joint effect of female sex and several minority race/ethnicity groups. Disparities were most pronounced in NHB and rural women, who had 5.4 and 3.3 times the odds of elevated LDL versus NHW and urban men after adjusting for important covariates. These striking effect sizes in a population at high cardiovascular risk (i.e., older with T2D) suggest interventions aimed at improving lipid management are needed for individuals falling into one or more groups known to face health disparities.
Sections du résumé
BACKGROUND
Cardiovascular (CV) disease is the leading cause of death among United States women. Rural residence and ethnic-minority status are individually associated with increased CV mortality. Managing dyslipidemia is important in the prevention of CV mortality. However, the impact of race/ethnicity and location of residence on sex differences in dyslipidemia management is not well understood. Therefore, we sought to understand the joint effects of race/ethnicity and location of residence on lipid management differences between veteran men and women with type 2 diabetes (T2D).
METHODS
Veterans Health Administration and Centers for Medicare and Medicaid Services data were used to perform a longitudinal cohort study of veterans with T2D (2007-2016). Mixed effects logistic regression with a random intercept was used to model the association between sex and low-density lipoprotein (LDL) > 100 mg/dL and its interaction with race/ethnicity and location of residence after adjusting for all measured covariates.
RESULTS
When female sex and rural location of residence were both present, they were associated with an antagonistic harmful effect on LDL. Similar antagonistic harmful effects on LDL were observed when the joint effect of female sex and several minority race/ethnicity groups were evaluated. After adjusting for measured covariates, the odds of LDL > 100 mg/dL were higher for urban women (OR = 2.66, 95%CI 2.48-2.85) and rural women (OR = 3.26, 95%CI 2.94-3.62), compared to urban men. The odds of LDL > 100 mg/dL was the highest among non-Hispanic Black (NHB) women (OR = 5.38, 95%CI 4.45-6.51) followed by non-Hispanic White (NHW) women (OR = 2.59, 95%CI 2.44-2.77), and Hispanic women (OR = 2.56, 95%CI 1.79-3.66).
CONCLUSION
Antagonistic harmful effects on LDL were observed when both female sex and rural location of residence were present. These antagonistic effects on LDL were also present when evaluating the joint effect of female sex and several minority race/ethnicity groups. Disparities were most pronounced in NHB and rural women, who had 5.4 and 3.3 times the odds of elevated LDL versus NHW and urban men after adjusting for important covariates. These striking effect sizes in a population at high cardiovascular risk (i.e., older with T2D) suggest interventions aimed at improving lipid management are needed for individuals falling into one or more groups known to face health disparities.
Identifiants
pubmed: 33059602
doi: 10.1186/s12872-020-01730-8
pii: 10.1186/s12872-020-01730-8
pmc: PMC7558630
doi:
Substances chimiques
Biomarkers
0
Cholesterol, LDL
0
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Types de publication
Comparative Study
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
449Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : VHA HSR&D funded grant
ID : HX001229
Pays : International
Références
Ann Pharmacother. 2019 Jul;53(7):675-682
pubmed: 30724092
J Am Heart Assoc. 2019 Apr 2;8(7):e011765
pubmed: 30913959
Soc Sci Med. 2018 Aug;211:198-206
pubmed: 29960171
Womens Health Issues. 2011 Jul-Aug;21(4 Suppl):S176-81
pubmed: 21724138
Ann Pharmacother. 2014 May;48(5):562-70
pubmed: 24586059
Public Health Rep. 2014 Jan-Feb;129(1):19-29
pubmed: 24381356
J Gen Intern Med. 2006 Mar;21 Suppl 3:S47-53
pubmed: 16637945
J Am Heart Assoc. 2017 May 10;6(5):
pubmed: 28490523
BMC Cardiovasc Disord. 2011 Sep 30;11:58
pubmed: 21961563
Int J Cardiol. 2010 Apr 15;140(2):226-35
pubmed: 19081646
Am Heart J. 2011 Oct;162(4):725-732.e1
pubmed: 21982666
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123
pubmed: 30559236
BMC Public Health. 2014 Jan 30;14:98
pubmed: 24479754
Womens Health Issues. 2014 Sep-Oct;24(5):575-80
pubmed: 25213750
Med Care. 2011 Jun;49(6):560-8
pubmed: 21422951
J Am Coll Cardiol. 2019 Jun 25;73(24):3210-3227
pubmed: 30423394
Womens Health Issues. 2014 Sep-Oct;24(5):477-83
pubmed: 25213741
MMWR Surveill Summ. 2017 Jan 13;66(1):1-8
pubmed: 28081058
Am J Cardiol. 2020 May 15;125(10):1492-1499
pubmed: 32245632
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Med Care. 2015 May;53(5):423-9
pubmed: 25811632
Circulation. 2019 Feb 19;139(8):1102-1109
pubmed: 30779640
Circulation. 2003 Sep 2;108(9):1089-94
pubmed: 12939228
Diabetes Care. 2015 Jul;38(7):1290-8
pubmed: 25852205
J Womens Health (Larchmt). 2017 Jul;26(7):806-814
pubmed: 28192012
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
J Rural Health. 2005 Spring;21(2):167-71
pubmed: 15859054
Health Equity. 2019 Sep 23;3(1):472-479
pubmed: 31576377
World Psychiatry. 2010 Oct;9(3):177-82
pubmed: 20975865
J Gen Intern Med. 2006 Mar;21 Suppl 3:S40-6
pubmed: 16637944
J Rural Health. 2014 Spring;30(2):146-52
pubmed: 24689540
Diabetes Care. 2012 Dec;35(12):2533-9
pubmed: 22912429